Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pharmacogenomic Testing clinical trials
1 of 3 indexed Pharmacogenomic Testing trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Pharmacogenomic Testing: 3 US clinical trials tracked, 1 recruiting.
Pharmacogenomic Testing is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Geisinger Clinic, running 1 of these trials.
Enrollment posture brief
Registry condition pharmacogenomic-testing
OPEN 1 | RECR 33% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Pharmacogenomic Testing lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pharmacogenomic Testing on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pharmacogenomic Testing is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
Florida Atlantic University
NCT07216846
Preemptive Pharmacogenomics Testing Among Geriatric Patients
Geisinger Clinic
NCT05091879
VICE-MPRINT: Maternal and Pediatric Pharmacogenetics Survey
Vanderbilt University Medical Center
NCT05037305
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Pharmacogenomic Testing records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pharmacogenomic Testing trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pharmacogenomic Testing page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Pharmacogenomic Testing trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Geisinger Clinic sponsors the most Pharmacogenomic Testing trials on record, review their full trial history before evaluating a specific study. See Geisinger Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pharmacogenomic Testing condition card totals 3 registered trials; most-linked intervention Multigene pharmacogenomics test; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.